Press releases
- Nordic Nanovector board member resigns
- Nordic Nanovector ASA: Extraordinary General Meeting held
- Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 3 January 2023
- Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics
- Nordic Nanovector Launches Dedicated Area on its Website in Norwegian for Information on the Proposed Merger with APIM Therapeutics
- Nordic Nanovector: Invitation to webcast regarding proposed merger with APIM Therapeutics
- Nordic Nanovector comment on Proposed Merger with APIM Therapeutics
- Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 1 December 2022
- Nordic Nanovector and APIM Therapeutics Announce Merger Agreement
- Nordic Nanovector Highlights Novel Humanized Anti-CD37 Therapeutic Antibody Candidates for B-cell Malignancies or B-cell-driven Autoimmune Disorders at ASH Annual Meeting
More ▼
Key statistics
As of last trade Nordic Nanovector ASA (8NN:MUN) traded at 0.0952, 0.00% above its 52-week low of 0.0952, set on Jan 27, 2023.
52-week range
Markit short selling activity
Open | 0.0952 |
---|---|
High | 0.0952 |
Low | 0.0952 |
Bid | 0.0773 |
Offer | 0.108 |
Previous close | 0.0952 |
Average volume | 0.00 |
---|---|
Shares outstanding | 116.04m |
Free float | 97.05m |
P/E (TTM) | -- |
Market cap | 117.89m NOK |
EPS (TTM) | -4.20 NOK |
Data delayed at least 15 minutes, as of Jan 30 2023 07:08 GMT.
More ▼